Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Alivus Life Sciences Ltd

NSE: ALIVUS · BSE: 543322 · Pharmaceuticals & Biotechnology · 9 announcements

Share price: ₹1,365.60
Market cap: ₹16,766 Cr
Revenue (annual): ₹2,552 Cr
Net profit (annual): ₹564.5 Cr
P/E (TTM): 27.8×Sector 50.4×
Promoter holding: 74.87%+0.00% QoQ
FII holding: 5.54%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 2 Merger & Restructuring 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

30 Jul 2026 18:44 IST NSE

Financial Results

Alivus Life Sciences Q1 FY27 Results: Net Profit ₹160.1 Cr, Up 31.8% YoY

Alivus Life Sciences Ltd reported revenue from operations of ₹640.4 Cr (+6.4% YoY) and net profit of ₹160.1 Cr (+31.8% YoY) for Q1 FY27.

Key figure: Net profit ₹160.1 Cr · +31.8% YoY

Open full results → Read the filing ↗

14 May 2026 19:34 IST NSE

Financial Results

Alivus Life Sciences Q4 FY26 Results: Net Profit ₹162.7 Cr, Up 14.7% YoY

Alivus Life Sciences Ltd reported revenue from operations of ₹689.1 Cr (+6.1% YoY) and net profit of ₹162.7 Cr (+14.7% YoY) for Q4 FY26.

Key figure: Net profit ₹162.7 Cr · +14.7% YoY

Open full results → Read the filing ↗